Base and prime editors (BEs and PEs) may provide more precise genetic engineering than nuclease-based approaches because they bypass the dependence on DNA double-strand breaks. However, little is known about their cellular responses and genotoxicity. Here, we compared state-of-the-art BEs and PEs and Cas9 in human hematopoietic stem and progenitor cells with respect to editing efficiency, cytotoxicity, transcriptomic changes and on-target and genome-wide genotoxicity. BEs and PEs induced detrimental transcriptional responses that reduced editing efficiency and hematopoietic repopulation in xenotransplants and also generated DNA double-strand breaks and genotoxic byproducts, including deletions and translocations, at a lower frequency than Cas9. These effects were strongest for cytidine BEs due to suboptimal inhibition of base excision repair and were mitigated by tailoring delivery timing and editor expression through optimized mRNA design. However, BEs altered the mutational landscape of hematopoietic stem and progenitor cells across the genome by increasing the load and relative proportions of nucleotide variants. These findings raise concerns about the genotoxicity of BEs and PEs and warrant further investigation in view of their clinical application.

Genotoxic effects of base and prime editing in human hematopoietic stem cells / Fiumara, M.; Ferrari, S.; Omer-Javed, A.; Beretta, S.; Albano, Luisa.; Canarutto, D.; Varesi, A.; Gaddoni, C.; Brombin, C.; Cugnata, F.; Zonari, E.; Naldini, M. M.; Barcella, M.; Gentner, B.; Merelli, I.; Naldini, L.. - In: NATURE BIOTECHNOLOGY. - ISSN 1087-0156. - 42:6(2024), pp. 877-891. [Epub ahead of print] [10.1038/s41587-023-01915-4]

Genotoxic effects of base and prime editing in human hematopoietic stem cells

Fiumara M.;Ferrari S.;Omer-Javed A.;Beretta S.;Canarutto D.;Brombin C.;Cugnata F.;Naldini M. M.;Naldini L.
2024-01-01

Abstract

Base and prime editors (BEs and PEs) may provide more precise genetic engineering than nuclease-based approaches because they bypass the dependence on DNA double-strand breaks. However, little is known about their cellular responses and genotoxicity. Here, we compared state-of-the-art BEs and PEs and Cas9 in human hematopoietic stem and progenitor cells with respect to editing efficiency, cytotoxicity, transcriptomic changes and on-target and genome-wide genotoxicity. BEs and PEs induced detrimental transcriptional responses that reduced editing efficiency and hematopoietic repopulation in xenotransplants and also generated DNA double-strand breaks and genotoxic byproducts, including deletions and translocations, at a lower frequency than Cas9. These effects were strongest for cytidine BEs due to suboptimal inhibition of base excision repair and were mitigated by tailoring delivery timing and editor expression through optimized mRNA design. However, BEs altered the mutational landscape of hematopoietic stem and progenitor cells across the genome by increasing the load and relative proportions of nucleotide variants. These findings raise concerns about the genotoxicity of BEs and PEs and warrant further investigation in view of their clinical application.
2024
Inglese
Nature Research
42
6
877
891
Epub ahead of print
https://www.nature.com/articles/s41587-023-01915-4
Esperti anonimi
Internazionale
Goal 3: Good health and well-being
No
Genotoxic effects of base and prime editing in human hematopoietic stem cells / Fiumara, M.; Ferrari, S.; Omer-Javed, A.; Beretta, S.; Albano, Luisa.; Canarutto, D.; Varesi, A.; Gaddoni, C.; Brombin, C.; Cugnata, F.; Zonari, E.; Naldini, M. M.; Barcella, M.; Gentner, B.; Merelli, I.; Naldini, L.. - In: NATURE BIOTECHNOLOGY. - ISSN 1087-0156. - 42:6(2024), pp. 877-891. [Epub ahead of print] [10.1038/s41587-023-01915-4]
open
16
info:eu-repo/semantics/article
262
Fiumara, M.; Ferrari, S.; Omer-Javed, A.; Beretta, S.; Albano, Luisa.; Canarutto, D.; Varesi, A.; Gaddoni, C.; Brombin, C.; Cugnata, F.; Zonari, E.; N...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
   Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application
   X-PAND
   European Commission
   Horizon Europe Framework Programme
   101070950
File in questo prodotto:
File Dimensione Formato  
s41587-023-01915-4-1.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 9.98 MB
Formato Adobe PDF
9.98 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/152976
Citazioni
  • ???jsp.display-item.citation.pmc??? 119
  • Scopus 146
  • ???jsp.display-item.citation.isi??? 158
social impact